1. Wong, SL, Faries, MB, Kennedy, EB et al: Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American society of clinical oncology and society of surgical oncology clinical practice guideline update. Ann Surg Oncol 2018;25:356–377.
Google Scholar | Crossref | Medline2. Faries, MB, Thompson, JF, Cochran, AJ et al: Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med 2017;376:2211–2222.
Google Scholar | Crossref | Medline3. Morton, DL, Thompson, JF, Cochran, AJ et al: Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 2014;370:599–609.
Google Scholar | Crossref | Medline | ISI4. Leiter, U, Stadler, R, Mauch, C et al: Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): A multicentre, randomised, phase 3 trial. Lancet Oncol 2016;17(6):757–767.
Google Scholar | Crossref | Medline5. Munsch, C, Lauwers-Cances, V, Lamant, L et al: Breslow thickness, Clark index and ulceration are associated with sentinel lymph node metastasis in melanoma patients: A cohort analysis of 612 patients. Dermatology 2014;229(3):183–189.
Google Scholar | Crossref | Medline6. Kunte, C, Geimer, T, Baumert, J et al: Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: An analysis of 1049 patients with cutaneous melanoma. Melanoma Res 2010;20(4):330–337.
Google Scholar | Crossref | Medline7. Cadili, A, Dabbs, K: Predictors of sentinel lymph node metastasis in melanoma. Can J Surg 2010;53:32–36.
Google Scholar | Medline8. Azimi, F, Scolyer, RA, Rumcheva, P et al: Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J Clin Oncol 2012;30:2678–2683.
Google Scholar | Crossref | Medline9. Egger, ME, Gilbert, JE, Burton, AL et al: Lymphovascular invasion as a prognostic factor in melanoma. Am Surg 2011;77(8):992–997.
Google Scholar | SAGE Journals10. White, RL, Ayers, GD, Stell, VH et al: Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database. Ann Surg Oncol 2011;18(13):3593–3600.
Google Scholar | Crossref | Medline11. Merkow, J, Paniccia, A, Jones, E et al: Association of sentinel lymph node diameter with melanoma metastasis. Am J Surg 2016;212(2):315–320.
Google Scholar | Crossref | Medline12. Wong, SL, Morton, DL, Thompson, JF et al: Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: A multi-institutional study. Ann Surg Oncol 2006;13:809–816.
Google Scholar | Crossref | Medline13. Leung, AM, Morton, DL, Ozao-Choy, J et al: Staging of regional lymph nodes in melanoma: A case for including nonsentinel lymph node positivity in the American Joint Committee on Cancer staging system. JAMA Surg 2013;148(9):879–884.
Google Scholar | Crossref | Medline14. Rutkowski, P, Szydłowski, K, Nowecki, ZI et al: The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique. World J Surg Oncol 2015;13:299.
Google Scholar | Crossref | Medline15. Sars, C, Gillgren, P, Schultz, I et al: Risk factors for complications and long-term outcomes following completion lymph node dissection for cutaneous melanoma: A retrospective cohort study. J Plast Reconstr Aesthet Surg 2020;73(8):1540–1546.
Google Scholar | Crossref | Medline16. Rios-Cantu, A, Lu, Y, Melendez-Elizondo, V et al: Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin. Clin Exp Metastasis 2017;34(5):345–350.
Google Scholar | Crossref | Medline17. Garbe, C, Amaral, T, Peris, K et al: European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics—Update 2019. Eur J Cancer 2020;126:141–158.
Google Scholar | Crossref | Medline18. Bluemel, C, Herrmann, K, Giammarile, F et al: EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma. Eur J Nucl Med Mol Imaging 2015;42(11):1750–1766.
Google Scholar | Crossref | Medline19. van der Ploeg, IM, Madu, MF, van der Hage, JA et al: Blue dye can be safely omitted in most sentinel node procedures for melanoma. Melanoma Res 2016;26(5):464–468.
Google Scholar | Crossref | Medline20. Jaukovic, L, Rajovic, M, Kandolf Sekulovic, L et al: Time to procedure, nuclear imaging and clinicopathological characteristics as predictive factors for sentinel lymph node metastasis in cutaneous melanoma: A single-center analysis. Ann Plast Surg 2018;81(1):80–86.
Google Scholar | Crossref | Medline21. de Rosa, N, Lyman, GH, Silbermins, D et al: Sentinel node biopsy for head and neck melanoma: A systematic review. Otolaryngol Head Neck Surg 2011;145:375–382.
Google Scholar | SAGE Journals | ISI22. Verwer, N, Scolyer, RA, Uren, RF et al: Treatment and prognostic significance of positive interval sentinel nodes in patients with primary cutaneous melanoma. Ann Surg Oncol 2011;18(12):3292–3299.
Google Scholar | Crossref | Medline23. Homolak, D, Situm, M, Cupic, H. Clinico-pathological features of patients with melanoma and positive sentinel lymph node biopsy: A single institution experience. Acta Dermatovenerol Croat 2015;23(2):122–129.
Google Scholar | Medline24. Bertolli, E, de Macedo, MP, Pinto, CA et al: Evaluation of melanoma features and their relationship with nodal disease: The importance of the pathological report. Tumori 2015;101(5):501–505.
Google Scholar | SAGE Journals25. Wada, M, Ito, T, Tsuji, G et al: Acral lentiginous melanoma versus other melanoma: A single-center analysis in Japan. J Dermatol 2017;44(8):932–938.
Google Scholar | Crossref | Medline26. Bradford, PT, Goldstein, AM, McMaster, ML et al: Acral lentiginous melanoma: Incidence and survival patterns in the United States, 1986-2005. Arch Dermatol 2009;145(4):427–434.
Google Scholar | Crossref | Medline27. Bertolli, E, Franke, V, Calsavara, VF et al: Validation of a nomogram for non-sentinel node positivity in melanoma patients, and its clinical implications: A Brazilian-Dutch study. Ann Surg Oncol 2019;26(2):395–405.
Google Scholar | Crossref | Medline28. Cochran, AJ, Wen, DR, Huang, RR et al: Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol 2004;17(7):747–755.
Google Scholar | Crossref | Medline29. Borgognoni, L, Bellucci, F, Urso, C et al: Enhancing the prognostic role of melanoma sentinel lymph nodes through microscopic tumour burden characterization: Clinical usefulness in patients who do not undergo complete lymph node dissection. Melanoma Res 2019;29:163–171.
Google Scholar | Crossref | Medline30. van Akkooi, AC, Bouwhuis, MG, de Wilt, JH et al: Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma. Br J Surg 2007;94:1293–1299.
Google Scholar | Crossref | Medline